Share This Page
Drug Price Trends for ENSKYCE
✉ Email this page to a colleague
Average Pharmacy Cost for ENSKYCE
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ENSKYCE 28 TABLET | 68180-0891-73 | 0.12171 | EACH | 2024-04-17 |
ENSKYCE 28 TABLET | 68180-0891-71 | 0.12171 | EACH | 2024-04-17 |
ENSKYCE 28 TABLET | 68180-0891-71 | 0.15908 | EACH | 2024-03-20 |
ENSKYCE 28 TABLET | 68180-0891-73 | 0.15908 | EACH | 2024-03-20 |
ENSKYCE 28 TABLET | 68180-0891-71 | 0.16287 | EACH | 2024-02-21 |
ENSKYCE 28 TABLET | 68180-0891-73 | 0.16287 | EACH | 2024-02-21 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Enskyce
Introduction to Enskyce
Enskyce is a combined oral contraceptive containing desogestrel and ethinyl estradiol, indicated for the prevention of pregnancy in women who choose oral contraceptives as their method of contraception. Here, we will delve into the market analysis and price projections for this medication.
Market Demand and Efficacy
Enskyce is part of the broader market for combined oral contraceptives, which are highly effective methods of contraception. The efficacy of Enskyce is well-documented, with a typical user-efficacy pregnancy rate of 1.12 per 100 women-years, including patients who did not take the drug correctly[1][3].
The demand for oral contraceptives remains steady due to their effectiveness and the ongoing need for reliable birth control methods. This consistent demand supports a stable market for Enskyce and similar products.
Pricing and Cost Considerations
The cost of Enskyce can vary depending on the pharmacy and the use of discount cards or patient assistance programs. Here are some key pricing points:
- Cash Price: A 30-day supply of Enskyce (84 tablets) can cost around $36.38, which translates to approximately $0.43 per unit[2].
- Discounts and Coupons: Patients can use discount cards, such as the Drugs.com Discount Card, to save up to 80% on the cost of Enskyce. Additionally, various coupons, copay cards, and rebates may be available to reduce the cost[2].
- Patient Assistance Programs: Programs like the Patient Access Network Foundation (PAN) offer cost-free or discounted medicines to individuals with low income or those who are uninsured or under-insured[2].
Market Competition
Enskyce competes in a crowded market with other combined oral contraceptives. Some of its competitors include:
- Apri
- Isibloom
- Kariva
- Volnea
- Other generic and brand-name versions of desogestrel and ethinyl estradiol[2].
The competition in this market is driven by factors such as efficacy, side effect profiles, cost, and patient preference.
Price Projections
Given the stable demand and competitive landscape, here are some insights into price projections for Enskyce:
-
Short-Term Projections: Prices for Enskyce are likely to remain stable in the short term due to the consistent demand for oral contraceptives and the availability of generic versions. Any significant price changes would likely be influenced by changes in manufacturing costs, regulatory factors, or shifts in market competition.
"The cost for Enskyce (0.15 mg-0.03 mg) oral tablet is around $36 for a supply of 84 tablets, depending on the pharmacy you visit."[2]
-
Long-Term Projections: In the long term, prices could be affected by several factors:
- Generic Competition: The presence of generic versions of desogestrel and ethinyl estradiol could lead to price reductions as more competitors enter the market.
- Regulatory Changes: Any changes in regulatory policies or healthcare reforms could impact the pricing of prescription medications, including Enskyce.
- Market Dynamics: Shifts in consumer preferences or the introduction of new contraceptive methods could influence the demand and pricing of Enskyce.
Patient Access and Affordability
Patient access and affordability are crucial factors in the market analysis of Enskyce. Here are some points to consider:
- Patient Assistance Programs: These programs play a significant role in making Enskyce more affordable for low-income or uninsured patients. For example, the Patient Access Network Foundation (PAN) offers cost-free or discounted medicines to eligible patients[2].
- Insurance Coverage: The cost of Enskyce can be significantly reduced for patients with insurance coverage that includes this medication.
Conclusion
Enskyce operates within a stable and competitive market for combined oral contraceptives. The pricing of Enskyce is influenced by factors such as manufacturing costs, market competition, and patient assistance programs. Here are the key takeaways:
Key Takeaways
- Stable Demand: The demand for oral contraceptives remains consistent, supporting a stable market for Enskyce.
- Pricing: The current cash price for a 30-day supply of Enskyce is around $36.38, with potential savings through discount cards and patient assistance programs.
- Market Competition: Enskyce competes with other combined oral contraceptives, both generic and brand-name.
- Price Projections: Short-term prices are expected to remain stable, while long-term prices could be influenced by generic competition, regulatory changes, and market dynamics.
- Patient Access: Patient assistance programs and insurance coverage play a critical role in making Enskyce more affordable.
FAQs
What is Enskyce used for?
Enskyce is used for the prevention of pregnancy in women who choose oral contraceptives as their method of contraception.
How effective is Enskyce?
Enskyce has a typical user-efficacy pregnancy rate of 1.12 per 100 women-years, including patients who did not take the drug correctly[1][3].
What is the cost of Enskyce?
A 30-day supply of Enskyce (84 tablets) can cost around $36.38, with potential savings through discount cards and patient assistance programs[2].
Are there any patient assistance programs available for Enskyce?
Yes, programs like the Patient Access Network Foundation (PAN) offer cost-free or discounted medicines to eligible patients[2].
Can I use Enskyce if I am over 35 and smoke?
No, combination oral contraceptives, including Enskyce, should not be used by women who are over 35 years of age and smoke due to increased cardiovascular risks[3].
Does Enskyce protect against sexually transmitted diseases?
No, Enskyce does not protect against HIV infection (AIDS) and other sexually transmitted diseases[3].
More… ↓